Sae Matsuoka

Tochigi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Structure-based prediction reveals a difference in the binding mode of anti-BCMA antibodies to BCMA and soluble BCMA.

Structure-based prediction reveals a difference in the binding mode of anti-BCMA antibodies to BCMA and soluble BCMA.

Journal: Leukemia
Published: August 04, 2025

FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1q.

FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1q.

Journal: Haematologica
Published: March 25, 2025

c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment.

c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment.

Journal: Cells
Published: January 31, 2025

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14).

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14).

Journal: Blood neoplasia
Published: August 20, 2024

Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells.

Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells.

Journal: PloS one
Published: June 17, 2024

Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells.

Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells.

Journal: Haematologica
Published: February 27, 2024

Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.

Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.

Journal: Leukemia research
Published: June 25, 2022

Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome.

Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome.

Journal: Internal medicine (Tokyo, Japan)
Published: April 04, 2022

Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation.

Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation.

Journal: Leukemia & lymphoma
Published: February 14, 2022

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.

Journal: Blood
Published: December 23, 2021

Risk Factors for Complications Associated with Peripherally Inserted Central Catheters During Induction Chemotherapy for Acute Myeloid Leukemia.

Risk Factors for Complications Associated with Peripherally Inserted Central Catheters During Induction Chemotherapy for Acute Myeloid Leukemia.

Journal: Internal medicine (Tokyo, Japan)
Published: September 13, 2021

Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysis.

Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysis.

Journal: Leukemia research
Published: August 03, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026